Cardiology Studies

Exploring the Therapeutic Mechanisms of Huzhang-Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking.

Li D et al (2021).
Evid Based Complement Alternat Med.
PubMed:
34887932

Systematic exploration of the potential material basis and molecular mechanism of the Mongolian medicine Nutmeg-5 in improving cardiac remodeling after myocardial infarction.

Liu T et al (2022).
J Ethnopharmacol.
PubMed:
34800647

Neuroprotective Effects of Rhodiola Sacra on Transient Global Cerebral Ischemia Through Activating AMPK/Nrf2 Pathway in Rats.

Rhodiola sacra is a component with many medicinal uses, including anti-oxidation and anti-inflammation. Researchers investigated its neuroprotective effects against transient global cerebral ischemia (tGCI) in male rats. They found that pretreatment or/and post-treatment significantly reduced neuronal injury, inhibited glial activation, and improved cognitive function. Molecular docking showed that Rhodiola sacra targets adenosine monophosphate-activated protein kinase (AMPK) α2-subunit and upregulates phosphorylated AMPK and nuclear factor erythroid 2-related factor 2 (Nrf2). Additionally, Rhodiola sacra increased heme oxygenase-1 (HO-1) expression and activity and reduced malondialdehyde (MDA) content in the hippocampal CA1 region. These findings demonstrate that Rhodiola sacra prevents oxidant stress and protects neurons through activating the AMPK/Nrf2 pathway.

Li K et al (2022).
Antioxid Redox Signal.
PubMed:
34714119

Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials.

Hibiscus sabdariffa significantly reduces blood pressure in patients with mild-to-moderate hypertension, but not in patients with metabolic syndrome or when compared to antihypertensive drugs. More research is needed for long-term efficacy.

Abdelmonem M et al (2022).
J Cardiovasc Pharmacol.
PubMed:
34694241